Acquisition Activity TMI recently expanded through asset acquisitions from Vyaire Medical and Apax Partners, signaling ongoing growth and potential for additional OEM partnerships or bolt-on opportunities to broaden their respiratory device portfolio.

Distribution Expansion New distribution agreements with Medikro Oy to bring drug-free Aerobika OPEP devices to Finland and Sweden indicate openness to regional partnerships; sales teams should target Nordic markets with complementary respiratory devices.

Product Collaboration Past partnerships with InCarda Therapeutics for portable nebulizers show readiness for co-development and contract manufacturing; explore opportunities for co-engineered nebulizers or adjunct devices for home use.

Service / OEM Opportunity With a focus on branded and custom respiratory devices and a strong manufacturing footprint, there's potential to offer white-label or customized drug-delivery solutions to pharmaceutical partners seeking scale and reliability.

Regional Growth Potential Revenue range positions mid-market size with room to grow; target mid-sized health systems and distributors in North America and Europe seeking cost-effective respiratory devices that improve patient outcomes and health-system savings.